539 related articles for article (PubMed ID: 27914067)
1. 5q- syndrome-like features as the first manifestation of myelodysplastic syndrome in a patient with an unbalanced whole-arm translocation der(5;19)(p10;q10).
Ureshino H; Kizuka H; Kusaba K; Sano H; Nishioka A; Shindo T; Kubota Y; Ando T; Kojima K; Kimura S
Int J Hematol; 2017 May; 105(5):692-696. PubMed ID: 27914067
[TBL] [Abstract][Full Text] [Related]
2. [Effective azacitidine treatment for myelodysplastic syndrome transformed from essential thrombocythemia].
Iizuka H; Yoshimi A; Yamamoto G; Masuda A; Nannya Y; Ichikawa M; Yatomi Y; Kurokawa M
Rinsho Ketsueki; 2013 May; 54(5):468-72. PubMed ID: 23727686
[TBL] [Abstract][Full Text] [Related]
3. Unbalanced whole-arm translocation der(5;19)(p10;q10) is a novel and recurrent cytogenetic aberration in myelodysplastic syndrome.
Yamamoto K; Okamura A; Katayama Y; Shimoyama M; Matsui T
Leuk Res; 2009 Mar; 33(3):377-83. PubMed ID: 18829109
[TBL] [Abstract][Full Text] [Related]
4. Unbalanced translocation der(1;7)(q10;p10) defines a unique clinicopathological subgroup of myeloid neoplasms.
Sanada M; Uike N; Ohyashiki K; Ozawa K; Lili W; Hangaishi A; Kanda Y; Chiba S; Kurokawa M; Omine M; Mitani K; Ogawa S
Leukemia; 2007 May; 21(5):992-7. PubMed ID: 17315020
[TBL] [Abstract][Full Text] [Related]
5. der(5;17)(p10;q10) is a recurrent but rare whole-arm translocation in patients with hematological neoplasms: a report of three cases.
Manabe M; Okita J; Tarakuwa T; Harada N; Aoyama Y; Kumura T; Ohta T; Furukawa Y; Mugitani A
Acta Haematol; 2014; 132(2):134-9. PubMed ID: 24556628
[TBL] [Abstract][Full Text] [Related]
6. Clinical management of myelodysplastic syndromes with interstitial deletion of chromosome 5q.
Nimer SD
J Clin Oncol; 2006 Jun; 24(16):2576-82. PubMed ID: 16735711
[TBL] [Abstract][Full Text] [Related]
7. [der(1;7) (q10;p10) in three patients with malignant hematologic disorders].
Yokoo H; Okada Y; Tominaga K; Tsuji M; Takagi T; Maseki N; Sakurai M; Kaneko Y
Rinsho Ketsueki; 1992 Dec; 33(12):1829-33. PubMed ID: 1479694
[TBL] [Abstract][Full Text] [Related]
8. Elliptocytosis in myelodysplastic syndrome associated with translocation (1;5)(p10;q10) and deletion of 20q.
Ishida F; Shimodaira S; Kobayashi H; Saito H; Kaku M; Kanzaki A; Yawata Y; Kitano K; Kiyosawa K
Cancer Genet Cytogenet; 1999 Jan; 108(2):162-5. PubMed ID: 9973947
[TBL] [Abstract][Full Text] [Related]
9. [Chromosomal structural changes in patients with myelodysplastic syndrome].
Yu Y; Liu XP; Liu SH; Yu MH; Zhang Y; Xiao ZJ
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(38):2693-7. PubMed ID: 18167247
[TBL] [Abstract][Full Text] [Related]
10. Whole-arm translocation of der(5;17)(p10;q10) with concurrent TP53 mutations in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS): A unique molecular-cytogenetic subgroup.
Hong M; Hao S; Patel KP; Kantarjian HM; Garcia-Manero G; Yin CC; Medeiros LJ; Lin P; Lu X
Cancer Genet; 2016 May; 209(5):205-14. PubMed ID: 27134073
[TBL] [Abstract][Full Text] [Related]
11. 5q- syndrome and multiple myeloma diagnosed simultaneously and successful treated with lenalidomide.
Ortega M; Mallo M; Solé F; Sánchez-Morata C; López-Andreoni L; Martínez-Morgado N; Gironella M; Valcárcel D; Vallespí T
Leuk Res; 2013 Oct; 37(10):1248-50. PubMed ID: 23891188
[TBL] [Abstract][Full Text] [Related]
12. Derivative (5;19)(p10;q10): a rare but recurrent whole-arm translocation in acute myeloid leukemia.
Manabe M; Takakuwa T; Nakano H; Harada N; Okamoto S; Aoyama Y; Kumura T; Ohta T; Furukawa Y; Matsuda M; Mugitani A
Asia Pac J Clin Oncol; 2014 Jun; 10(2):e122-6. PubMed ID: 23279927
[TBL] [Abstract][Full Text] [Related]
13. Does MDS with der(1;7)(q10;p10) constitute a distinct risk group? A retrospective single institutional analysis of clinical/pathologic features compared to -7/del(7q) MDS.
Slovak ML; O'Donnell M; Smith DD; Gaal K
Cancer Genet Cytogenet; 2009 Sep; 193(2):78-85. PubMed ID: 19665067
[TBL] [Abstract][Full Text] [Related]
14. New complex t(2;11;17)(p21;q23;q11), a variant form of t(2;11), associated with del(5)(q23q32) in myelodysplastic syndrome-derived acute myeloblastic leukemia.
Yamamoto K; Nagata K; Morita Y; Inagaki K; Hamaguchi H
Cancer Genet Cytogenet; 2002 Sep; 137(2):119-23. PubMed ID: 12393282
[TBL] [Abstract][Full Text] [Related]
15. Treatment of Patients With Myelodysplastic Syndrome With Lenalidomide in Clinical Routine in Austria.
Aschauer G; Greil R; Linkesch W; Nösslinger T; Stauder R; Burgstaller S; Fiegl M; Fridrik M; Girschikofsky M; Keil F; Petzer A
Clin Lymphoma Myeloma Leuk; 2015 Nov; 15(11):e143-9. PubMed ID: 26422252
[TBL] [Abstract][Full Text] [Related]
16. [Myelodysplastic syndrome with der (1;7)(q10;p10) complicated with eosinophilia and organizing pneumonia].
Komura A; Meguri Y; Matsubara C; Fujiwara H; Yukawa R; Hayashino K; Nakamura M; Yoshida C; Yamamoto K; Matsuoka KI; Fujii N; Maeda Y; Imajo K
Rinsho Ketsueki; 2023; 64(7):619-625. PubMed ID: 37544721
[TBL] [Abstract][Full Text] [Related]
17. Lenalidomide: a review of its use in patients with transfusion-dependent anaemia due to low- or intermediate-1-risk myelodysplastic syndrome associated with 5q chromosome deletion.
Syed YY; Scott LJ
Drugs; 2013 Jul; 73(11):1183-96. PubMed ID: 23824699
[TBL] [Abstract][Full Text] [Related]
18. Higher-risk myelodysplastic syndromes with del(5q): is sequential azacitidine-lenalidomide combination the way to go?
Zeidan AM; Gore SD; Komrokji RS
Expert Rev Hematol; 2013 Jun; 6(3):251-4. PubMed ID: 23782079
[TBL] [Abstract][Full Text] [Related]
19. [Characteristics of myelodysplastic syndromes with der(1;7)(q10;p10)].
Okuda R
Rinsho Ketsueki; 2023; 64(12):1519-1522. PubMed ID: 38220152
[TBL] [Abstract][Full Text] [Related]
20. Derivative (1;7)(q10;p10) in multiple myeloma. A sign of therapy-related hidden myelodysplastic syndrome.
Ishii Y; Hsiao HH; Sashida G; Ito Y; Miyazawa K; Kodama A; Ohyashiki JH; Ohyashiki K
Cancer Genet Cytogenet; 2006 Jun; 167(2):131-7. PubMed ID: 16737912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
